You are now leaving the Amgen.ca website.

The linked sites are not under the control of Amgen, and Amgen is not responsible for the content available on the linked sites. Such links do not imply Amgen's endorsement of material on any other site, and Amgen disclaims all liability with regard to your access to such linked websites. Amgen provides links to other Internet sites as a convenience to users, and access to such linked sites is at your own risk.


Do you want to link to our other external sites and leave Amgen.ca?


You are now leaving the Amgen Canada website. Please note that the information you are about to view may not comply with Canadian regulatory requirements. Marketing authorizations and availability of products may differ between Canada and other countries.

You are now leaving the external site website.


The linked sites are not under the control of Amgen, and Amgen is not responsible for the content available on the linked sites. Such links do not imply Amgen's endorsement of material on any other site, and Amgen disclaims all liability with regard to your access to such linked websites. Amgen provides links to other Internet sites as a convenience to users, and access to such linked sites is at your own risk.

Do you want to link to another Amgen Canada site?


You are now leaving the Amgen Canada website. Please note that these links are being provided as a convenience and for informational purposes only.

UNIVERSITY OF TORONTO AND AMGEN FOUNDATION PARTNER TO BRING PRESTIGIOUS AMGEN SCHOLARS PROGRAM TO CANADA

Four-year grant offers Canadian undergraduate students the opportunity to gain hands-on research experience with world-leading U of T researchers

Toronto, ON (November 1, 2018) – Today, the University of Toronto (U of T) is pleased to announce the launch of the Amgen Scholars Canada Program, an immersive research program that offers undergraduate students the opportunity to engage in cutting-edge research, be mentored by some of U of T’s world-renowned scientists, and deepen their understanding of medical biotechnology. This is the first time the Amgen Scholars program has been offered in Canada.

Beginning in 2019, 15 undergraduate students from across Canada will be welcomed to Toronto for a 10-week research placement at the University of Toronto’s Faculty of Medicine and Leslie Dan Faculty of Pharmacy. The program aims to increase learning and networking opportunities for students committed to pursuing a career in science or engineering.

During their time as Canada’s Amgen Scholars, students will:

Canada’s Amgen Scholars will also have the chance to experience Toronto’s unique biomedical ecosystem. U of T is the research and educational hub within Toronto’s vibrant network of world-leading hospitals and health care sites, and the only Faculty of Medicine in the vibrant and diverse Greater Toronto Area of six million people.

Financial support for students is also a critical component of the program, which offers fully-funded research opportunities to students, independent of financial status.

By helping aspiring scientists delve into world-leading biomedical research — and breaking down barriers they may face, whether due to socioeconomic status, geographical location, or belonging to historically marginalized groups — the Amgen Scholars Canada Program is poised to inspire and equip a new generation of homegrown health leaders and innovative researchers.

Representatives of U of T and Amgen also expressed their support for the importance and value of the Amgen Scholars Program in Canada:


ABOUT THE AMGEN SCHOLARS PROGRAM

Since its inception in 2006, the Amgen Scholars Program has made research opportunities at premier institutions possible for more than 4,000 undergraduate students from over 700 colleges and universities who have participated to date.

Of those alumni who have completed their undergraduate studies, nearly 900 are currently pursuing an advanced graduate degree in a scientific field, and another 280 have earned their Ph.D. or M.D.-Ph.D. More than 500 are employed in scientific fields across 33 countries, with 99 percent of surveyed alumni saying the program impacted their academic or professional direction.

Amgen Scholars is now hosted at 24 top institutions across the U.S., Europe, Asia, and for the first time in 2019, China, Singapore, Australia and Canada. The Amgen Foundation will commit more than $21 million to the Amgen Scholars Program through 2022, totaling a $74 million investment over 16 years.

U of T is now accepting applications for the 2019 Amgen Scholars Canada Program, until February 1, 2019. For more information, or to apply, visit http://www.glse.utoronto.ca/amgen-scholars-canada-program and follow us on Twitter at @uoftmedicine, @UofTPharmacy and @AmgenFoundation

About the University of Toronto

Established in 1827, the University of Toronto (U of T) is Canada’s largest university, recognized as a global leader in research and teaching.  The university consistently ranks among the top 25 universities in the world. Its distinguished faculty, institutional record of groundbreaking scholarship and wealth of innovative academic opportunities continually attract outstanding academics and students from around the world and across its three campuses. Known for the discovery of insulin, stem cells, the first electronic heart pacemaker and first lung transplant, U of T is the research and educational hub within one of North America’s largest biomedical clusters.

About the Amgen Foundation

The Amgen Foundation seeks to advance excellence in science education to inspire the next generation of innovators and to invest in strengthening communities where Amgen staff members live and work. To date, the Foundation has donated over $300 million to local, regional and international nonprofit organizations that impact society in inspiring and innovative ways. For more information, visit www.AmgenInspires.com and follow us on Twitter at @AmgenFoundation.

About Amgen Canada

As a leader in innovation, Amgen Canada understands the value of science. With main operations located in Mississauga, Ont.'s vibrant biomedical cluster, and its research facility in Burnaby, B.C., Amgen Canada has been an important contributor to advancements in science and innovation in Canada since 1991. The company contributes to the development of new therapies and new uses for existing medicines in partnership with many of Canada's leading health-care, academic, research, government and patient organizations. To learn more about Amgen Canada, visit www.amgen.ca.